Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Participate in webinars on financial planning topics led by experts. These sessions are designed to enhance your knowledge and help you make informed decisions.
17,885 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A senior comms exec says AI notetakers are moving from convenience to liability as governance gaps and confidential n...
Corporate treasuries are redefining crypto investing. This deep dive looks at how Strategy amassed a sizable Bitcoin ...
Aave’s UK units Push Labs Ltd. and Push Virtual Assets Ltd. have won FCA registration to run crypto asset exchange se...
Variant has closed a $222 million fund aimed at early-stage crypto and AI ventures that expand user autonomy in finan...
As traditional markets push higher, crypto faces a tougher path. This guide breaks down whether there reason left cry...
As IPO chatter heats up in 2026, SpaceX faces a pivotal moment. The CFO’s quiet leadership could define the deal, unl...
When a legendary entrepreneur speaks, markets listen. This article breaks down what an Elon Musk makes shocking predi...
A routine bank alert turned into a high-stakes investigation when authorities traced suspicious activity to two suspe...
World Cup 2026 in the U.S. has sparked a spending spree among fans who travel with dreams of the tournament, even if ...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A seven-year high in regional bank M&A signals bigger players aiming for scale and efficiency. This guide breaks down...